Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Close this folder7. The editorial process
View the document7.1 Outline of the editorial process
Open this folder and view contents7.2 Editing a drug bulletin
Open this folder and view contents7.3 Writing bulletin articles
Open this folder and view contents7.4 Reviewing the article
View the document7.5. Rewriting the article
View the document7.6 Final checks
Close this folder7.7 Follow-up after publication
View the document7.7.1 Indexing
View the document7.7.2 Authors’ certificates
View the document7.7.3 Post-publication correspondence
View the document7.7.4 Corrections
View the document7.7.5 Requests for reproduction
View the document7.7.6 Keeping track of how bulletin articles are quoted and used
View the document7.8 References
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

7.7.4 Corrections

A section devoted to errata, corrections or clarifications, is a good criterion for quality. Mistakes are bound to occur from time to time, and scientific matters often require supplementary information. Quality control mechanisms should be in place to avoid them as far as possible. However hard one tries to avoid making mistakes, they do arise. If the bulletin is to remain trusted, it must publish a 'correction' as soon as possible. It might feel awkward to make a correction, but it is more important to correct errors and possibly save lives, than to remain quiet in the hope that the bulletin's reputation will remain intact. The prompt publication of a correction is a way of allowing readers to see that you are honest and trustworthy.

The UK’s Drug and Therapeutics Bulletin was the first bulletin to include a section for errata, followed by many other ISDB bulletins. Since bulletins often have a faithful readership, readers are likely to see corrections or clarifications published in the following issue. Readers should be encouraged to point out errors they notice in the bulletin or statements that are ambiguous or too vague. The corrections or clarifications need to be included in the index.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014